DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases
Biomolecules · 2023
DOI: 10.3390/biom13101503 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Thomas Klonisch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E…. Hauptthemen laut MEDLINE: Ubiquitin, Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Council of Canada (NSERC).
Abstract (Originalsprache)
The ubiquitin proteasome system (UPS) utilizes an orchestrated enzymatic cascade of E1, E2, and E3 ligases to add single or multiple ubiquitin-like molecules as post-translational modification (PTM) to proteins. Ubiquitination can alter protein functions and/or mark ubiquitinated proteins for proteasomal degradation but deubiquitinases (DUBs) can reverse protein ubiquitination. While the importance of DUBs as regulatory factors in the UPS is undisputed, many questions remain on DUB selectivity for protein targeting, their mechanism of action, and the impact of DUBs on the regulation of diverse biological processes. Furthermore, little is known about the expression and role of DUBs in tumors of the human central nervous system (CNS). In this comprehensive review, we have used publicly available transcriptional datasets to determine the gene expression profiles of 99 deubiquitinases (DUBs) from five major DUB families in seven primary pediatric and adult CNS tumor entities. Our analysis identified selected DUBs as potential new functional players and biomarkers with prognostic value in specific subtypes of primary CNS tumors. Collectively, our analysis highlights an emerging role for DUBs in regulating CNS tumor cell biology and offers a rationale for future therapeutic targeting of DUBs in CNS tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Department of Medical Microbiology & Infectious Diseases, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- CancerCare Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0J9, Canada.
ORCID-Profile: Thomas Klonisch, Sabine Hombach-Klonisch
Förderung
- Natural Sciences and Engineering Council of Canada (NSERC)
Zitieren
APA
Klonisch, T., Logue, S. E., Hombach-Klonisch, S., & Vriend, J. (2023). DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. Biomolecules. https://doi.org/10.3390/biom13101503
Vancouver
Klonisch T, Logue SE, Hombach-Klonisch S, Vriend J. DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. Biomolecules. 2023. doi:10.3390/biom13101503
BibTeX
@article{Klonisch2023,
author = {Klonisch, Thomas and Logue, Susan E and Hombach-Klonisch, Sabine and Vriend, Jerry},
title = {DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13101503}
}
EUVIMED